Benzinga | May 11, 2021 09:06AM EDT

Aptevo Therapeutics Q1 EPS $(1.64) Down From $0.89 YoY

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(1.64) per share. This is a 284.27 percent decrease over earnings of $0.89 per share from the same period last year.